ProfileGDS4132 / 205701_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 63% 67% 42% 38% 68% 61% 54% 58% 40% 47% 36% 38% 37% 36% 25% 39% 32% 35% 41% 36% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101180.81263
GSM201543Muscle PCOS pioglitazone 121184.55967
GSM201544Muscle PCOS pioglitazone 161110.8942
GSM201545Muscle PCOS pioglitazone 201104.61838
GSM201829Muscle PCOS pioglitazone 231212.86768
GSM201830Muscle PCOS pioglitazon 251178.54261
GSM201831Muscle PCOS pioglitazone 271151.38954
GSM201832Muscle PCOS pioglitazone 31154.65458
GSM201833Muscle PCOS pioglitazone 4197.84940
GSM201834Muscle PCOS pioglitazone 81122.38147
GSM201835Muscle PCOS after pioglitazone 10277.016436
GSM201836Muscle PCOS after pioglitazone 12285.945338
GSM201837Muscle PCOS after pioglitazone 16279.818737
GSM201838Muscle PCOS after pioglitazone 20282.915736
GSM201839Muscle PCOS after pioglitazone 23252.212725
GSM201840Muscle PCOS after pioglitazone 25297.215139
GSM201841Muscle PCOS after pioglitazone 27265.919232
GSM201842Muscle PCOS after pioglitazone 3270.916735
GSM201843Muscle PCOS after pioglitazone 42103.2541
GSM201844Muscle PCOS after pioglitazone 8285.359936